TY - JOUR
T1 - Intrabronchial Valves for Air Leaks After Lobectomy, Segmentectomy, and Lung Volume Reduction Surgery
AU - Abu-Hijleh, Muhanned
AU - Styrvoky, Kim
AU - Anand, Vikram
AU - Woll, Fernando
AU - Yarmus, Lonny
AU - Machuzak, Michael S.
AU - Nader, Daniel A.
AU - Mullett, Timothy W.
AU - Hogarth, D. Kyle
AU - Toth, Jennifer W.
AU - Acash, Ghazwan
AU - Casal, Roberto F.
AU - Hazelrigg, Stephen
AU - Wood, Douglas E.
N1 - Funding Information:
This was a post marketing registry supported by research grants from Spiration (Olympus/Spiration Inc., Redmond, WA, US).
Publisher Copyright:
© 2019, Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2019/10/1
Y1 - 2019/10/1
N2 - Purpose: Air leaks are common after lobectomy, segmentectomy, and lung volume reduction surgery (LVRS). This can increase post-operative morbidity, cost, and hospital length of stay. The management of post-pulmonary resection air leaks remains challenging. Minimally invasive effective interventions are necessary. The Spiration Valve System (SVS, Olympus/Spiration Inc., Redmond, WA, US) is approved by the FDA under humanitarian use exemption for management of prolonged air leaks. Methods: This is a prospective multicenter registry of 39 patients with air leaks after lobectomy, segmentectomy, and LVRS managed with an intention to use bronchoscopic SVS to resolve air leaks. Results: Bronchoscopic SVS placement was feasible in 82.1% of patients (32/39 patients) and 90 valves were placed with a median of 2 valves per patient (mean of 2.7 ± 1.5 valves, range of 1 to 7 valves). Positive response to SVS placement was documented in 76.9% of all patients (30/39 patients) and in 93.8% of patients when SVS placement was feasible (30/32 patients). Air leaks ultimately resolved when SVS placement was feasible in 87.5% of patients (28/32 patients), after a median of 2.5 days (mean ± SD of 8.9 ± 12.4 days). Considering all patients with an intention to treat analysis, bronchoscopic SVS procedure likely contributed to resolution of air leaks in 71.8% of patients (28/39 patients). The post-procedure median hospital stay was 4 days (mean 6.0 ± 6.1 days). Conclusions: This prospective registry adds to the growing body of literature supporting feasible and effective management of air leaks utilizing one-way valves.
AB - Purpose: Air leaks are common after lobectomy, segmentectomy, and lung volume reduction surgery (LVRS). This can increase post-operative morbidity, cost, and hospital length of stay. The management of post-pulmonary resection air leaks remains challenging. Minimally invasive effective interventions are necessary. The Spiration Valve System (SVS, Olympus/Spiration Inc., Redmond, WA, US) is approved by the FDA under humanitarian use exemption for management of prolonged air leaks. Methods: This is a prospective multicenter registry of 39 patients with air leaks after lobectomy, segmentectomy, and LVRS managed with an intention to use bronchoscopic SVS to resolve air leaks. Results: Bronchoscopic SVS placement was feasible in 82.1% of patients (32/39 patients) and 90 valves were placed with a median of 2 valves per patient (mean of 2.7 ± 1.5 valves, range of 1 to 7 valves). Positive response to SVS placement was documented in 76.9% of all patients (30/39 patients) and in 93.8% of patients when SVS placement was feasible (30/32 patients). Air leaks ultimately resolved when SVS placement was feasible in 87.5% of patients (28/32 patients), after a median of 2.5 days (mean ± SD of 8.9 ± 12.4 days). Considering all patients with an intention to treat analysis, bronchoscopic SVS procedure likely contributed to resolution of air leaks in 71.8% of patients (28/39 patients). The post-procedure median hospital stay was 4 days (mean 6.0 ± 6.1 days). Conclusions: This prospective registry adds to the growing body of literature supporting feasible and effective management of air leaks utilizing one-way valves.
UR - http://www.scopus.com/inward/record.url?scp=85072028349&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85072028349&partnerID=8YFLogxK
U2 - 10.1007/s00408-019-00268-7
DO - 10.1007/s00408-019-00268-7
M3 - Article
C2 - 31463549
AN - SCOPUS:85072028349
SN - 0341-2040
VL - 197
SP - 627
EP - 633
JO - Lung
JF - Lung
IS - 5
ER -